These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization. Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382 [TBL] [Abstract][Full Text] [Related]
5. [Analysis and perinatal outcome after intravascular transfusion]. Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826 [TBL] [Abstract][Full Text] [Related]
6. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845 [TBL] [Abstract][Full Text] [Related]
7. Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review. Lindenburg IT; van Klink JM; Smits-Wintjens VE; van Kamp IL; Oepkes D; Lopriore E Prenat Diagn; 2013 Sep; 33(9):815-22. PubMed ID: 23658134 [TBL] [Abstract][Full Text] [Related]
9. Intrauterine blood transfusion: current indications and associated risks. Lindenburg IT; van Kamp IL; Oepkes D Fetal Diagn Ther; 2014; 36(4):263-71. PubMed ID: 24903741 [TBL] [Abstract][Full Text] [Related]
10. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Tiblad E; Kublickas M; Ajne G; Bui TH; Ek S; Karlsson A; Wikman A; Westgren M Fetal Diagn Ther; 2011; 30(4):266-73. PubMed ID: 22024691 [TBL] [Abstract][Full Text] [Related]
11. Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia. Oepkes D; Adama van Scheltema P Semin Fetal Neonatal Med; 2007 Dec; 12(6):432-8. PubMed ID: 17706475 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options. Papantoniou N; Sifakis S; Antsaklis A J Perinat Med; 2013 Jan; 41(1):71-82. PubMed ID: 23093258 [TBL] [Abstract][Full Text] [Related]
13. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion. Lakhwani S; Machado P; Pecos P; Coloma M; Rebollo S; Raya JM Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196 [TBL] [Abstract][Full Text] [Related]
14. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021 [TBL] [Abstract][Full Text] [Related]
15. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization. Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958 [TBL] [Abstract][Full Text] [Related]
16. Brain ultrasound findings in neonates treated with intrauterine transfusion for fetal anaemia. Leijser LM; Vos N; Walther FJ; van Wezel-Meijler G Early Hum Dev; 2012 Sep; 88(9):717-24. PubMed ID: 22445567 [TBL] [Abstract][Full Text] [Related]
18. Implementation of routine screening for Kell antibodies: does it improve perinatal survival? Kamphuis MM; Lindenburg I; van Kamp IL; Meerman RH; Kanhai HH; Oepkes D Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569 [TBL] [Abstract][Full Text] [Related]